{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Inside U.S. Regulations","title":"[USA] Regulatory Insights on Enforcement, AI, and Cancer Drug Guidance","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/94210f38\"></iframe>","width":"100%","height":180,"duration":269,"description":"Covering Draft Guidance, Capital Markets, Cancer Drugs, Regulation Best Interest, Enforcement. Explore key regulatory updates on enforcement actions, AI supervisory tools in capital markets, draft guidance to reduce animal testing in cancer drug development, and compliance under Regulation Best Interest.","thumbnail_url":"https://img.transistorcdn.com/Awx10XbYhgLkeEbOlMycmsGKMrGLlBsOrbrzhvNG_xM/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83YmI2/MGU0ZTk1Zjk5NmVh/YzM3ZTg0NjkyMmVk/ZjI1Ni5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}